B16 melanoma in C57BL/6 – prophylactic immunization model with critical involvement of CD4+ and CD8+ T cells (15, 37); E.G7 (SCCVII) in C57BL/6 – curative vaccination model (40). This evidence concerns the gene CD4 and melanoma.